Get the Stockscreener App
1.62
1.89%
0.03
After Hours:
1.61
-0.01
-0.62%
Enveric Biosciences Inc stock is traded at $1.62, with a volume of 157.67K.
It is up +1.89% in the last 24 hours and up +20.00% over the past month.
Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. The company is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, which is being studied as a treatment for psychiatric disorders.
See More
Previous Close:
$1.59
Open:
$1.62
24h Volume:
157.67K
Relative Volume:
1.10
Market Cap:
$7.25M
Revenue:
-
Net Income/Loss:
$-8.22M
P/E Ratio:
-0.0592
EPS:
-27.3467
Net Cash Flow:
$-8.01M
1W Performance:
+14.08%
1M Performance:
+20.00%
6M Performance:
-19.40%
1Y Performance:
-78.57%
1-Day Range:
$1.5194
$1.6494
1-Week Range:
$1.4098
$1.6494
52-Week Range:
$1.1701
$13.25
Enveric Biosciences Inc Stock (ENVB) Company Profile
Name
Enveric Biosciences Inc
Sector
Industry
Phone
(617) 444-8400
Address
245 FIRST STREET RIVERVIEW II 18TH FLOOR, CAMBRIDGE
Compare ENVB vs VRTX, REGN, ARGX, MRNA, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ENVB
Enveric Biosciences Inc
|
1.62 | 6.36M | 0 | -8.22M | -8.01M | -27.35 |
VRTX
Vertex Pharmaceuticals Inc
|
508.34 | 130.64B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
784.85 | 80.46B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
990.32 | 61.58B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
154.04 | 57.48B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
190.95 | 43.68B | 742.00K | -1.37B | -1.07B | -7.0731 |
Enveric Biosciences Inc Stock (ENVB) Latest News
ENVB Price Today: Enveric Biosciences, Inc. Stock Price, Quote & Chart | MEXC - MEXC
Enveric Biosciences Announces Withdrawal Of Petition Against Its Patent — ENVB Stock Rises - Stocktwits
Enveric Biosciences Inc (NASDAQ: ENVB) Share Price, ENVB Stock News, ENVB Share Price & Updates - Kalkine
Enveric Biosciences to Present at H.C. Wainwright 28th Annual Global Investment Conference - ca.finance.yahoo.com
Enveric Biosciences Inc. (ENVB) Peer Comparison – Compare with Others - Value Research
ARMISTICE CAPITAL, LLC Acquires Stake in Enveric Biosciences Inc (ENVB) - GuruFocus
Enveric (ENVB) Shares: Advances 6.11% to $1.39 in the Latest Reading; Key Range - vinanet.vn
Enveric (ENVB) Snapshot: Slides 0.74% to $1.34 in the Latest Reading; Technical View: Support at $1.27 and Resistance at $1.41 Frame the Range in Latest TradingFundamental Weighted - vinanet.vn
Enveric (ENVB) Daily Review: Moves 8.78% Lower to $1.35 for the Current Session; Price-Level Context: the Supplied Trading Band Runs From $1.28 to $1.42 in Latest TradingVanna Flow - vinanet.vn
Enveric Biosciences (ENVB) Q2 Results Highlight Challenges Amid Low Valuation Signals - GuruFocus
Enveric Biosciences Reports Financial Results and Provides Corporate Update for Second Quarter 2026 - BioSpace
Form 8K Enveric Biosciences Inc For: 14 August By Investing.com - Investing.com Nigeria
Enveric Biosciences reports $3.0M net loss, $8.3M cash on hand for Q2 2026 - TradingView
Enveric Biosciences (ENVB) posts H1 2026 loss but raises $8.3M cash - Stock Titan
Enveric Biosciences Posts $3.0 Million Second-Quarter Net Loss - Quiver Quantitative
Enveric Biosciences (NASDAQ: ENVB) deepens Q2 loss while pushing EB-003 toward trials - Stock Titan
Enveric Biosciences (ENVB) holders Lind entities report 1.3–1.4% warrant-based stake - Stock Titan
Armistice Capital (ENVB) discloses 405,092-share position in Enveric Biosciences - Stock Titan
Enveric Biosciences (ENVB) investors disclose 2.93% stake via 111,145-share warrants - Stock Titan
FDA Fast-Tracks Psychedelic Research After Trump’s Executive Order — CMPS, HELP Stocks Gain - Stocktwits
ENVB Q4 2024 Earnings: Net Loss of $57.60 Per Share Massively Misses Consensus EstimateTech Earnings Analysis - vinanet.vn
ENVB Q4 2024 Earnings: Per-Share Loss of -57.6 Overshoots Consensus by 1,946%Management Guidance Update - vinanet.vn
Enveric Biosciences (ENVB) Slides 7.19% to $1.55 — Stock Approaches Key Support at $1.47Index Put Call - vinanet.vn
Enveric Biosciences Says New Preclinical Data Confirms Non-Hallucinogenic Profile For Lead Psychiatric Ca - Benzinga
Enveric reports preclinical data on EB-003 drug candidate By Investing.com - Investing.com Canada
Enveric Biosciences Reports New Preclinical Data Supporting the Non-Hallucinogenic Profile of Lead Candidate EB-003 - Yahoo! Finance Canada
Enveric Biosciences (ENVB) Rallies 8.4% to $1.57 — Key Levels to WatchStock Analysis - dars.gov.et
ENVB Q4 2024 Earnings: Loss Deepens to -57.6 per Share, Yet Stock Climbs 8.43%Weak Earnings Momentum - vinanet.vn
Enveric Biosciences Welcomes Final FDA Guidance for Psychedelic Drug Development - Investing News Network
Enveric Biosciences Welcomes FDA's Guidance on Psychedelic Clinical Trials - Intellectia AI
Enveric Biosciences Inc (ENVB) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
ENVB|Enveric Biosciences Inc|Price:1.137|Chg%:-0.203 - TradingKey
TradingKey - TradingKey
ENVB|Enveric Biosciences Inc|Price:1.370|Chg%:-0.090 - tradingkey.com
Enveric Biosciences Inc (ENVB) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Enveric Biosciences (ENVB) Slides to $1.29, Testing Key Support at $1.23Positive Gamma - vinanet.vn
Enveric Biosciences Inc (ENVB) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Enveric Biosciences Shares Edge Lower as Support Level ApproachesVolume Profile - vinanet.vn
ENVB Q4 2024 Earnings: Massive EPS Miss Highlights Pre-Revenue Biotech ChallengesEstimate Revision Count - vinanet.vn
ENVB Q4 2024 Earnings: Sharp EPS Miss Triggers Stock DeclinePretax Income Report - vinanet.vn
ENVB Technical Analysis | Trend, Signals & Chart Patterns - ChartMill
Stock market today: Perfect Moment posted rise of 89.86% whereas Enveric Biosciences saw fall of 45.64% in early trading - Business Upturn
ENVB Q4 2024 Earnings: Significant EPS Miss Amid Continued Pipeline DevelopmentQuarterly Financial Update - vinanet.vn
Enveric Biosciences Inc (ENVB:UW): Stock Price, Quote and News - BNN Bloomberg
Price to sales forward of Enveric Biosciences, Inc. – NASDAQ:ENVB - TradingView
Price to sales forward of Enveric Biosciences, Inc. – BOATS:ENVB - TradingView
MSN Money - MSN
Enterprise value to EBITDA forward of Enveric Biosciences, Inc. – NASDAQ:ENVB - TradingView
Price to book forward of Enveric Biosciences, Inc. – NASDAQ:ENVB - TradingView
Enveric Biosciences (ENVB) Slips 5.6%: Testing Key Support as Biotech Sentiment WanesJelly Roll Trade - dars.gov.et
Enveric Biosciences (ENVB) Rebounds Slightly, Testing Key Resistance Near $1.50Earnings Miss Risk - dars.gov.et
Enveric Biosciences Inc Stock (ENVB) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.88%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):